HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recurrence of idiopathic pulmonary hemosiderosis in a young adult patient after bilateral single-lung transplantation.

AbstractBACKGROUND:
Idiopathic pulmonary hemosiderosis (IPH) is a rare disease of unknown etiology characterized by hemoptysis, diffuse pulmonary infiltration, and anemia. Diagnosis requires a detailed clinical history and transbronchial lung biopsy (TLB).
METHODS AND RESULTS:
A 19-year-old man developed progressive dyspnea, hemoptysis, and anemia. The chest x-rays showed bilateral opacities. IPH was diagnosed on the basis of clinical findings and TLB. The patient was treated with corticosteroidal therapy. His respiratory function worsened, and he underwent lung transplantation in 1997. The pathological examination on native lungs confirmed the previous histologic diagnosis. In 2000, the patient again developed hemoptysis, fever, and hypoxemia. A recurrence of the disease was established by TLB.
CONCLUSIONS:
This is the first report of recurring IPH. The possibility of recurrent IPH raises the question whether these patients should be disqualified from lung transplantation. This question is unanswerable because incidence of recurrence, time course, and impact on the graft function are presently unknown and unpredictable.
AuthorsFiorella Calabrese, Cinzia Giacometti, Federico Rea, Monica Loy, Francesco Sartori, Giuseppe Di Vittorio, Aierken Abudureheman, Gaetano Thiene, Marialuisa Valente
JournalTransplantation (Transplantation) Vol. 74 Issue 11 Pg. 1643-5 (Dec 15 2002) ISSN: 0041-1337 [Print] United States
PMID12490803 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Hemosiderosis (pathology, surgery)
  • Humans
  • Lung (pathology)
  • Lung Diseases (pathology, surgery)
  • Lung Transplantation
  • Male
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: